Hepatitis B Virus X Protein Inhibits the Expression of Barrier To Autointegration factor1 via Upregulating miR-203 Expression in Hepatic Cells

• Published in: Microbiology spectrum Vol. 11; no. 1; p. e0123522
• Main Authors: Mishra, Amit Kumar, Hossain, Md Musa, Sata, Teja Naveen, Yadav, Ajay K, Zadran, Shahidullah, Sah, Amrendra Kumar, Nayak, Baibaswata, Shalimar, Venugopal, Senthil Kumar
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 14-02-2023
• Subjects: BANF1; DNA-Binding Proteins - genetics; DNA-Binding Proteins - metabolism; HBx; Hepatitis B - genetics; Hepatitis B - metabolism; Hepatitis B - virology; hepatitis B virus; Hepatitis B virus - genetics; Hepatocytes - metabolism; Hepatocytes - virology; host restriction factor; Humans; microRNA-203; MicroRNAs - genetics; MicroRNAs - metabolism; Research Article; Trans-Activators - genetics; Trans-Activators - metabolism; Viral Regulatory and Accessory Proteins - metabolism; Virology; BANF1; microRNA-203; hepatitis B virus; host restriction factor; HBx
• ISSN: 2165-0497; 2165-0497
• DOI: 10.1128/spectrum.01235-22

Hepatitis B virus (HBV) infection targets host restriction factors that inhibit its replication and survival. Previous studies have shown that barriers to autointegration factor1 (BANF1) inhibited the replication of herpes simplex virus and vaccinia virus by binding to phosphate backbone of dsDNA. To date, no reports are available for the interplay between BANF1 and HBV. In this study, we elucidated the mechanisms by which HBV inhibit BANF1. First, the effect of HBV on BANF1 was observed in Huh-7, Hep G2, and Hep G2.2.15 cells. Huh-7 cells were transfected with pHBV
or HBx plasmids. The results showed that there was a decreased expression of BANF1 in Hep G2.2.15 cells (
 ≤ 0.005) or in HBV/HBx expressing Huh-7 cells (
 ≤ 0.005), whereas BANF1 overexpression decreased viral replication (
 ≤ 0.05). To study whether phosphorylation/dephosphorylation of BANF1 was responsible for antiviral activity, mutants were created, and it was found that inhibition due to mutants was less significant compared to BANF1 wild type. Previous studies have shown that HBV, at least in part, could regulate the expression of host miRNAs via HBx. It was found that miR-203 expression was high in Hep G2.2.15 cells (
 ≤ 0.005) compared to Hep G2 cells. Next, the effect of HBx on miR-203 expression was studied and result showed that HBx upregulated miR-203 expression (
 ≤ 0.005). Overexpression of miR-203 downregulated BANF1 expression (
 ≤ 0.05) and viral titer was upregulated (
 ≤ 0.05), while inhibition of miR-203, reversed these changes. In conclusion, BANF1 downregulated HBV, whereas HBV inhibited BANF1, at least in part, via HBx-mediated miR-203 upregulation in hepatic cells.
In this study, for the first time, we found that BANF1 inhibited HBV replication and restricted the viral load. However, as previously reported for other viruses, the results in this study showed that BAF1 phosphorylation/dephosphorylation is not involved in its antiviral activity against HBV. HBV infection inhibited the intracellular expression of BANF1, via HBx-mediated upregulation of miR-203 expression. Overexpression of miR-203 downregulated BANF1 and increased the viral titer, while inhibition of miR-203 reversed these changes. This study helped us to understand the molecular mechanisms by which HBV survives and replicates in the host cells.